Company intelligence / Profile preview

Anola Skin

Ownership: Private
Development stage: Other

Overview

All Anola Skin products are marketed for cosmetic and skincare use, targeting pigmentation disorders and uneven skin tone with plant-based, clinically tested formulations. No drug candidates, clinical trials, or regulated pharmaceutical indications were found. Products are positioned as effective for fading hyperpigmentation and improving overall skin appearance within weeks of use, with testimonials and strong customer following but lacking formal publication of clinical data.

Therapeutic areas: EndocrinologyDermatology
Modalities: Small moleculeProteinPeptidesVitaminSupplement
Industry: Food & Nutrition

Beyond the preview

Go deeper on Anola Skin.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Anola Skin.

Explore the full profile